Member Info for BoNidel

See he bought another 5000 @ 1.42 on 30/12/22.

Come on accustem, show your colours

Meant to say 2023!

Announced in 2020, delivered in 2024?…

Best of luck to all holders. Let’s hope GC has held it back because of market conditions and had a good way to hit the ground running in the new year. Best of luck to long suffering Tiziana holders as well.

Surely we should see a return to $100-$150m MCAP if trials are announced and the SPMS results continue to be good?

Has anyone here got any comments as to the loan we have made to okyo?

As GC I’m guessing is the biggest shareholder in both this is a little bit close to the line.

Raising capital through one company to give to another?

I also don’t understand HOW we are burning so much cash! How have they spent $7m odd. With only $26.5m left of the $57m raise.

Say that again. $30 odd million in 2 years, and what do we have

Taken from the interim results,

“ Postbalancesheetevents
In August 2022, the Group issued a short-term credit facility to Okyo Pharma, a related party, for $2m in order to support short term liquidity. The loan is available for a period of 6 months upon first draw-down and carries an interest rate of 16% per annum, with additional default interest of 4% if the loan is not repaid after the 6-month period. To date, $1m has been drawn down against the loan.”

Nice to see we are lending Okyo pharma and others cash…

Also, I note the following RE buyback

“ Treasury Shares
The Company acquired 912,825 of its own shares through purchases on the NASDAQ stock exchange during the period ended 30th June 2022. The total amount paid to acquire the shares, was $808k. The shares are held as “treasury shares”. The Company has the right to reissue these shares at a later date. All shares issued by the Company were fully paid.”

So we should have plenty of cash to keep it above $1 for 10 days.

All I want for Christmas is something meaningful from accustem.

That’s 3 xmas without anything concrete!

I have picked up loads more of them over the past year, maybe it will get me out of trouble with tils, who knows. Best of luck to all accuscam holders for 2023

Doesn’t look like we are getting one in 2022.

I suppose it’s been 2+ years anyway. What difference does another make?

I’m sure I remember the plumber chap mentioning on Twitter “dual listing off the bat” in early 2021.

I wonder if he is still investing in companies involved with GC! ??

Volume appears to have ground to a halt again. Does anyone here have any inkling as to how long the next stage of the SPO/IPO/Uplisting (or whatever you want to call it) will take.

I have tried to make this apparent to people here but to be fair after 2 YEARS of waiting and nothing happening, I can understand if people have lost faith and interest .

https://www.**********.co.uk/articles/traders-cafe-with-zak-mir-sunday-roast-extra-may-23rd-with-gabriele-cerrone-tiziana-life-sciences-tils-and-okyo-pharma-okyo--4c80e1e/

On this interview in may 21’ he states at 1:00:20 not sure on SP of accustem but mentions +30p/40p/50p/60p

I’m guessing that was at the time when there were approx 200m TILS shares in issue so theoretically 200m accustem entitlements.

If we went for 30p/share in old money then it would have given a £60m MCAP Uk side,

If it’s only 15p/share per old Tiziana entitlement/accustem share then That is theoretically £30m MCAP in sterling.

So maybe $36m-$72m MCAP in dollars which would give a share price of around $3-$6. I may just be talking rubbish and it’s a blind gamble but it’s a lot of upside from current $15m MCAP.

For the record, I think the cheapest I bought accustem was around $0.55c or below (after the consolidation).

Actually, it was 20:1 reverse split for old TILS entitlement so you’d have needed 20,000 old shares at a cost of around £1.80 so £36k

I’ve grabbed a few thousand more this week. Shouldn’t have as my average for accustem is actually pretty low due to the blind gambling I have done with it the last year or so but feel a bit of FOMO.

Current price is 1.10! That makes MCAP of around 12m dollars, I don’t think the TILS placing shares are active even so maybe sub 10m MCAP

9333 today

So who’s buying, and who’s selling ?

I suppose they don’t need them yet. Think of a piece of land that’s for a housing development. You need hundreds of men to build it but the land is still worth 10’s/100’s of millions just with the planning granted

Google accustem SPO (secondary public offering) and you will see that Nasdaq has some details now.

I wonder if we will get any update this year on pricing etc or what they are doing

Interestingly they would have taken a pile at 1.85 recently (bid). Thought this was really starting to loge now, surprised to see it moving back a bit

Mine too. Spoke to HL, nothing updated on their side. Wait ‘til market opens at 2:30 and call back if the same

Stupidly low volume. 800 odd today and that was mainly by an apparent LSE member.

If only they would give us something, this would sky rocket

Seems to have dropped off again. Doesn’t seem to be much buying although that being said, doesn’t appear to be a lot of stock available!

Would be great to have an update on Accustem soon, it’s only been 2 years.

Any other fools like me still buying Tiziana shares sometimes? For no other reason than the desperate hope that we are “averaging down”.

Showing as 6500 ish but trade data doesn’t reflect that (more like 450)